Shares of ITUS Corporation (NASDAQ:ITUS) are currently poised at -37.22% from the open today and are trading at $1.13. More than 325,100 shares have exchanged hands compared to an average trading volume of 32.85K. At the current pps, the market cap stands at $11.82M. The stock prices of ITUS Corporation (NASDAQ:ITUS) are currently trading at -83.43% below its 52 week high and -37.22% above its 52 week low.
ITUS Corporation (NASDAQ:ITUS) has been in the news for all the right reasons. Recently, ITUS Corporation (NASDAQ:ITUS) announced that its presentation at the American Association of Cancer Research conference in Washington, D.C. is now available. The presentation is highly technical in nature, and is geared to the scientific community.
ITUS Corporation (NASDAQ:ITUS) is all set to announce its earnings on -. As per Zack’s analyst ratings, ITUS Corporation (NASDAQ:ITUS) currently has an average brokerage rating of . On a scale of 1 to 5, a rating of 1 or 2 would indicate a buy, and a rating of 4 or 5 would signify a sell recommendation. A rating of 3 would indicate a hold on the stock. The consensus target price on (NASDAQ:ITUS) is $ with a high of $ and a low of $.
The Exponential Moving Average (EMA) is similar to a simple moving average (average price over a set period) but it utilizes a weighting factor that exponentially declines from the most recent data point (recent prices are weighted higher than oil prices). EMA analysis compares the short term (5 days and 13 days), intermediate term (20 days) and long term (50 days) EMA’s. The respective EMA’s will give bullish signals when trading above trailing EMA’s and below the current price and vice versa. EMA alerts include crossovers (i.e the 5 day EMA crosses above/below the 20 day EMA) and EMA convergencies (5 day EMA equivalent to 13 day EMA). The 5 day EMA 1.65 is higher than the last trade price suggesting a short term bearish pattern building up. Long term, the 50 day EMA 2.80 is also higher than the current trading price depicting a bearish trend overall.
Let’s take a look at the technical analysis.
The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions. Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.
The relative strength index (RSI) is a momentum oscillator that is able to measure the velocity and magnitude of stock price changes. Momentum is calculated as the ratio of positive price changes to negative price changes. The RSI analysis compares the current RSI against neutral(50), oversold (30) and overbought (70) conditions. Alerts will inform you when stocks recede from oversold/overbought levels or breakthrough neutral (50). The current RSI is 19.09 suggesting a bearish price action.
As such, while we believe ITUS Corporation (NASDAQ:ITUS) represents a compelling growth story exposed to several secularly attractive markets, it would be interesting to see how it fairs for long-term investors.
ITUS Corporation is developing a platform called Cchek, a series of non-invasive blood tests for the early detection of tumor based cancers.